News

October 20, 2017October 21, 2017

Vitamin D Supplements Reduce Asthma Flare-ups, Study Shows

Asthma, News

Vitamin D supplements reduce asthma flare-ups that require treatment with systemic corticosteroids, regardless of patients’ age, ethnicity, body-mass index, use of inhaled corticoids, or vitamin D levels before starting supplements, ... Read more

October 19, 2017October 19, 2017

FDA Giving Priority Review to Gilotriftm as Treatment for Rare Form of Lung Cancer

Lung Cancer, News

The U.S. Food and Drug Administration is giving priority review to Boehringer Ingelheim’s request that the agency consider approving Gilotriftm (afatinib) for an additional category of lung cancer patients. Gilotriftm is already approved ... Read more

October 18, 2017October 18, 2017

New Blocker of TGF-β1 Shows Promise as Potential Therapy for IPF Patients

Idiopathic Pulmonary Fibrosis, News

Blocking TGF-β1 — a known signaling pathway involved in tissue fibrosis — by compounds called trihydrophenolics halted fibrosis development and tissue stiffness in animal models of pulmonary fibrosis, new research shows. The ... Read more

October 18, 2017October 18, 2017

Pulmonary Rehabilitation Improves Patients’ Ability to Exercise and Quality of Life, Study Reports

Idiopathic Pulmonary Fibrosis, News

Pulmonary rehabilitation programs can improve exercise capacity and health-related quality of life in patients with interstitial lung diseases (ILDs), including those with pulmonary fibrosis, a study shows. These findings support ... Read more

October 17, 2017October 17, 2017

Opdivo, Alone or Combined with Yervoy, Extends Lung Cancer Patients’ Survival, Phase 1/2 Trial Shows

Lung Cancer, News

Opdivo (nivolumab) has shown promise as a treatment for recurring small lung cancer patients who have a lot of genetic errors in their tumors, according to a Phase 1/2 clinical trial. ... Read more

October 13, 2017October 13, 2017

Pulmonary Fibrosis Foundation’s Awareness Walk Raises Over $230K for Research

News

The Pulmonary Fibrosis Foundation‘s (PFF) inaugural walk in Chicago on Sept. 9 to kick off Pulmonary Fibrosis Awareness Month far exceeded expectations, drawing over 1,000 participants and helping to raise ... Read more

October 12, 2017October 13, 2017

Vibativ Displays More Punch Against Bacteria Than Other Antibiotics, Studies Show

Cystic Fibrosis, News, Pneumonia

Vibativ (telavancin) displays more punch against the Staphylococcus aureus bacteria that is involved in lung diseases than other antibiotics it has been tested against, according to presentations in San Diego this month. This ... Read more

October 11, 2017October 11, 2017

Potential Oral Asthma Therapy Enters Phase 1 Clinical Development, OncoArendi Says

Asthma, News

Germany’s top regulatory agency has approved a Phase 1 clinical study in healthy volunteers of OATD-01, an investigative asthma drug developed by Poland’s OncoArendi Therapeutics. The approval by Germany’s Federal Institute for ... Read more

October 10, 2017October 10, 2017

Duke Undergrads to Do Medical Research, Including Developing Tool to Spot CF Infections

Cystic Fibrosis, News

Two teams of Duke University undergraduates will be doing health research that is normally the purview of graduate students and professors, including a cystic fibrosis infections project. The 13 students from the Center ... Read more

October 9, 2017October 9, 2017

Bacteria-derived Factor R1R2 Has Potential as Antifibrotic Medication, Mouse Study Suggests

News

Taiwanese researchers are examining a new factor, R1R2, that may be able to stop fibrosis-promoting cells from migrating to the lungs. Their study, “R1R2 peptide ameliorates pulmonary fibrosis in mice ... Read more